Opioid

Baltimore Wins $266 Million in Landmark Opioid Case, Total Recovery Surpasses $668 Million

by

Baltimore, MD — In a significant legal victory, the city of Baltimore was awarded $266 million in damages from McKesson and AmerisourceBergen, two major pharmaceutical firms, due to their roles in the local opioid crisis. This decision reflects the city’s proactive approach in handling its opioid litigation independent of the nationwide settlement involving several states and municipalities. The city previously chose not to join the 2021 national opioid settlement, which included agreements with Cardinal Health, McKesson, AmerisourceBergen, and Johnson & Johnson. Instead, Baltimore pursued individual settlements and legal battles, previously securing more than three times … Read more

Baltimore Wins $274 Million Verdict Against Drug Distributors for Fueling Opioid Crisis

by

BALTIMORE — In a significant legal decision, a jury recently sided with Baltimore, finding that two prominent drug distributors played a crucial role in exacerbating the city’s opioid crisis by distributing hundreds of millions of painkillers. The verdict concluded with an award of $274 million in damages to the city, spotlighting the ongoing national debate over accountability in the opioid epidemic. The decision came after the jury found that McKesson Corp. and AmerisourceBergen Corp., which together controlled 60% of Baltimore’s opioid market for roughly a decade, were responsible for the public nuisance by unreasonably flooding … Read more

Baltimore Strikes $80 Million Deal with Walgreens to Address Opioid Crisis Impact

by

Baltimore, Maryland – In a significant legal victory, the city of Baltimore has achieved an $80 million settlement with Walgreens and a $266 million damages award against drug distributors McKesson and Amerisource-Bergen. These outcomes mark a serious commitment to addressing the opioid crisis that has devastated communities across the city. Announced last month, the Walgreens settlement resolves the city’s claims against the pharmacy giant for its involvement in exacerbating the opioid epidemic. The terms of the agreement stipulate that Walgreens will pay $45 million by the end of this year, with the remaining $35 million … Read more

Supreme Court to Deliver Landmark Ruling in Purdue Pharma Bankruptcy, A Potent Closure to an Opioid Saga

by

Washington, D.C. — The United States Supreme Court is poised to deliver its decision on the bankruptcy case of Purdue Pharma LP, marking a significant milestone in the ongoing battle against the opioid epidemic, a crisis responsible for over 750,000 deaths between 1999 and 2022. This forthcoming opinion is expected to address numerous legal and ethical issues surrounding one of the most notorious pharmaceutical giants in recent history. Purdue Pharma, widely criticized for its role in the opioid crisis, sought bankruptcy protection to manage the wave of lawsuits alleging it aggressively marketed OxyContin despite knowing … Read more